4-Amino-furazan-3-carboxylic acid ethyl ester, 98.0%, 100g

4-Bromo-isothiazole, 98.0%, 1g

2,7-Dichloro-9H-fluorene, 95.0%, 500g

Methyl 4-fluoro-1H-indole-7-carboxylate, 95%, 250mg

4-Chloro-1,3,5-triazin-2-amine, 95%, 500mg

3,4-Dimethoxy-2-methylbenzoic acid, 95.0%, 5g

E-Plan phase EPLPH 10x/0.25 objective. Working distance 6.61 mm

2-Bromo-3,4,5-trimethoxy-benzaldehyde, 95%, 5g

1-(4-Cyanopyridin-2-yl)piperidine-4-carboxylic acid, 1g

3-Phenylbutan-1-amine, 95%, 1g

5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-, hydrochloride (1:1), 25mg

N-([1,1'-Biphenyl]-4-yl)-[1,1'-biphenyl]-3-amine, 97%, 250mg

(4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methanol hydrochloride, 95.0%, 10g